John A. Auchampach

6.9k total citations · 1 hit paper
109 papers, 5.6k citations indexed

About

John A. Auchampach is a scholar working on Molecular Biology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, John A. Auchampach has authored 109 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 52 papers in Physiology and 44 papers in Pathology and Forensic Medicine. Recurrent topics in John A. Auchampach's work include Adenosine and Purinergic Signaling (52 papers), Cardiac Ischemia and Reperfusion (44 papers) and Receptor Mechanisms and Signaling (27 papers). John A. Auchampach is often cited by papers focused on Adenosine and Purinergic Signaling (52 papers), Cardiac Ischemia and Reperfusion (44 papers) and Receptor Mechanisms and Signaling (27 papers). John A. Auchampach collaborates with scholars based in United States, Italy and United Kingdom. John A. Auchampach's co-authors include G J Gross, Tina C. Wan, Garrett J. Gross, Cecilia J. Hillard, Erica J. Carrier, Roberto Bolli, Icilio Cavero, Zhi‐Dong Ge, Elizabeth Gizewski and Laura M. Kreckler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

John A. Auchampach

108 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

1992 754 citations G J Gross, John A. Auchampach profile →

Peers

John A. Auchampach

PFM

PHYSI

CCM

Gabriela González United States

Bruce T. Liang United States

Lydia Aguilar‐Bryan United States

John P. Clement United States

Robert D. Lasley United States

Aleksandar Jovanović United Kingdom

Lei Xi United States

Jeffrey M. Gidday United States

Volodymyr Gerzanich United States

Kirsti Ytrehus Norway

Gabriela González United States

John A. Auchampach

2.8k ×1.1

PFM

2.5k ×1.5

248 ×0.2

PHYSI

777 ×0.5

1.0k ×0.8

CCM

Citations per year, relative to John A. Auchampach John A. Auchampach (= 1×) peers Gabriela González

Countries citing papers authored by John A. Auchampach

Since Specialization

Citations

This map shows the geographic impact of John A. Auchampach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Auchampach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Auchampach more than expected).

Fields of papers citing papers by John A. Auchampach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Auchampach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Auchampach. The network helps show where John A. Auchampach may publish in the future.

Co-authorship network of co-authors of John A. Auchampach

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Auchampach. A scholar is included among the top collaborators of John A. Auchampach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Auchampach. John A. Auchampach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pavan, Matteo, Tina C. Wan, Marc López‐Cano, et al.. (2025). Bitopic A₃ Adenosine Receptor Molecular Probes: Positive Allosteric Modulation and Noncanonical Activation. Journal of Medicinal Chemistry. 68(19). 20717–20740.

Pavan, Matteo, Veronica Salmaso, Tina C. Wan, et al.. (2024). Lipid Trolling to Optimize A₃ Adenosine Receptor-Positive Allosteric Modulators (PAMs). Journal of Medicinal Chemistry. 67(14). 12221–12247. 6 indexed citations

Tosh, Dilip K., Matteo Pavan, Chunxia Cronin, et al.. (2024). 2-Substituted (N)-Methanocarba A₃ Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization. ACS Pharmacology & Translational Science. 7(7). 2154–2173. 4 indexed citations

Tosh, Dilip K., Veronica Salmaso, Tina C. Wan, et al.. (2023). First Potent Macrocyclic A₃ Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences. ACS Pharmacology & Translational Science. 6(9). 1288–1305. 2 indexed citations

Tosh, Dilip K., Veronica Salmaso, Eline Pottie, et al.. (2021). A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity. European Journal of Medicinal Chemistry. 228. 113983–113983. 6 indexed citations

Nayak, Shraddha, Abdul H. Khan, Tina C. Wan, et al.. (2015). Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension. Purinergic Signalling. 11(4). 519–531. 10 indexed citations

Kriska, Tamás, Tina C. Wan, John A. Auchampach, et al.. (2013). Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts. Prostaglandins & Other Lipid Mediators. 106. 8–15. 8 indexed citations

Wan, Tina C., Dilip K. Tosh, Lili Du, et al.. (2011). Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts. BMC Pharmacology. 11(1). 11–11. 20 indexed citations

Hoeven, Dharini van der, Elizabeth Gizewski, & John A. Auchampach. (2010). Activation of the A3 adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils. Biochemical Pharmacology. 79(11). 1667–1673. 9 indexed citations

10.

Ge, Zhi‐Dong, Danijel Pravdić, Martin Bienengraeber, et al.. (2009). Isoflurane Postconditioning Protects against Reperfusion Injury by Preventing Mitochondrial Permeability Transition by an Endothelial Nitric Oxide Synthase–dependent Mechanism. Anesthesiology. 112(1). 73–85. 69 indexed citations

11.

Auchampach, John A., Elizabeth Gizewski, Tina C. Wan, et al.. (2009). Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor. Biochemical Pharmacology. 79(7). 967–973. 21 indexed citations

12.

Nelson, Timothy J., Zhi‐Dong Ge, Matthew Barron, et al.. (2006). Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology. 288A(11). 1216–1224. 50 indexed citations

13.

Ge, Zhi‐Dong, Jason N. Peart, Laura M. Kreckler, et al.. (2006). Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine Receptor. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1200–1210. 81 indexed citations

14.

Kreckler, Laura M., Tina C. Wan, Zhi‐Dong Ge, & John A. Auchampach. (2006). Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor. Journal of Pharmacology and Experimental Therapeutics. 317(1). 172–180. 179 indexed citations

15.

Ge, Zhi‐Dong, et al.. (2003). Comparison of Cardioprotective Efficacy of Two Thromboxane A2 Receptor Antagonists. Journal of Cardiovascular Pharmacology. 41(3). 481–488. 10 indexed citations

16.

Auchampach, John A., Xiaowei Jin, Tina C. Wan, George H. Caughey, & Joel Linden. (1997). Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor. Molecular Pharmacology. 52(5). 846–860. 171 indexed citations

17.

Manning, Anthony, John A. Auchampach, Roger F. Drong, & Jerry L. Slightom. (1995). Cloning of a canine cDNA homologous to the human transforming growth factor-β1-encoding gene. Gene. 155(2). 307–308. 13 indexed citations

18.

Auchampach, John A., et al.. (1994). Cardioprotective Actions of Potassium Channel Openers. European Heart Journal. 15(suppl C). 89–94. 16 indexed citations

19.

Auchampach, John A., Icilio Cavero, & Garrett J. Gross. (1992). Nicorandil Attenuates Myocardial Dysfunction Associated with Transient Ischemia by Opening ATP-Dependent Potassium Channels. Journal of Cardiovascular Pharmacology. 20(5). 765–771. 32 indexed citations

20.

Gross, G J & John A. Auchampach. (1992). Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovascular Research. 26(11). 1011–1016. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact